JPRN-jRCT2080224926已完成1 期
Phase I study of Tiragolumab in patients with advanced solid tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •ECOG Performance Status of 0 or 1
- •- Histologically or cytologically documented solid tumors
- •- Evaluable lesion by image
排除标准
- •- History of severe adverse reaction by treatment with previous cancer immunotherapy
- •- History or complication of autoimmune disease
- •- Meningeal metastasis or metastasis to the central nervous system requiring treatment or accompanied by symptoms
研究者
相似试验
进行中（未招募）
2 期
A study to assess the effect of tiragolumab in presence of atezolizumab and bevacizumab in participants detected with lung canceron-squamous non-small cell lung cancerCancerISRCTN10010669F. Hoffmann-La Roche Ltd43
进行中（未招募）
1 期
Phase II Trial of Ipilimumab in Patients with advanced melanoma and spontaneous preexisting immune response to NY-ESO-1 - CTLA-4 NY-ESO-1EUCTR2009-016631-35-DEniversitätsklinikum Heidelberg25
进行中（未招募）
1 期
Phase II study of Atezolizumab plus Tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal.Squamous cell carcinoma of the anal canalMedDRA version: 26.0Level: LLTClassification code: 10084945Term: Basaloid squamous cell carcinoma of the anal canal Class: 100000004848CTIS2023-509485-38-00Grupo Espanol Multidisciplinar En Cancer Digestivo45
招募中
1 期
Phase 1 study of Tobemstomig in patients with advanced solid tumorsJPRN-jRCT2031230196oriko Yanagitani18
已完成
不适用
Prospective study on the effects of adalimumab treatment in patients with rheumatoid arthritisMusculoskeletal DiseasesArthropathiesRheumatoid arthritisISRCTN68762628Academic Medical Center (AMC) (The Netherlands)50